FIELD: medicine; medical engineering. SUBSTANCE: method involves injecting cross-linked, polymerized, tetramer-free pyridoxy-blended hemoglobin solution to human patients in the amount reaching 5 l. Leukocytes and blood platelets are removed from blood. Erythrocytes are washed and subjected to lysis. Stroma admixtures and stroma are removed by means of filtration and heat treatment. Desoxyhemoglobin form is produced. Pyridoxylation and polymerization, cleaning and condensing and deoxigenation are carried out next to it. EFFECT: no toxicity; considerable half-life period of 15 h order. 18 cl, 6 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
POLYMERISED HAEMOGLOBIN SOLUTIONS WITH LOWERED TETRAMER CONTENT AND METHOD OF PRODUCTION THEREOF | 2004 |
|
RU2337705C2 |
METHOD OF MEDICAL TREATMENT OF PATIENTS WITH HEAVY BLOOD LOSS | 2003 |
|
RU2325924C2 |
BLOOD SUBSTITUTE WITH FUNCTION OF OXYGEN TRANSFER, PHARMACEUTICAL COMPOSITION (VERSIONS) | 2008 |
|
RU2361608C1 |
CONJUGATES OF HEMOGLOBIN WITH POLYSACCHARIDE | 1999 |
|
RU2225222C2 |
POLYFUNCTIONAL POLYHEMOGLOBIN-ENZYME COMPLEX | 2010 |
|
RU2432172C1 |
METHOD OF BLOOD SUBSTITUTE PRODUCTION AND RELATED INSTALLATION FOR METHOD IMPLEMENTATION | 2007 |
|
RU2341286C1 |
METHOD FOR PREPARING HIGH-TEMPERATURE STABLE PHARMACEUTICAL COMPOSITION CONTAINING OXYGEN CARRIER AND USING IT | 2011 |
|
RU2475252C1 |
USE OF POLYMERIZED HEMOGLOBIN FOR MOBILIZATION OF BLOOD FROM DEPOT IN CASE OF BLOOD LOSS | 2021 |
|
RU2811253C2 |
BLOOD SUBSTITUTE AS OXYGEN TRANSPORTER, COMPOSITION FOR ITS PREPARING AND METHOD OF POLYMERIC MODIFIED HEMOGLOBIN PREPARING | 1999 |
|
RU2162707C2 |
METHOD OF COMMERCIAL-SCALE PURIFICATION OF HEMOGLOBIN | 1994 |
|
RU2145873C1 |
Authors
Dates
2003-04-27—Published
1997-03-27—Filed